Rocket Pharmaceuticals (RCKT) Insider Trading & Ownership $8.01 +0.15 (+1.91%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$8.09 +0.08 (+1.00%) As of 05/2/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.50%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$200,765.30Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$588,757.00 Get RCKT Insider Trade Alerts Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RCKT Insider Buying and Selling by Quarter Rocket Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/22/2025John MilitelloInsiderSell718$7.16$5,140.88 4/10/2025Gaurav ShahCEOBuy20,000$5.08$101,600.00 4/9/2025Kinnari PatelInsiderBuy21,099$4.70$99,165.30 4/4/2025Aaron OndreyCFOSell7,489$5.29$39,616.81 1/23/2025John MilitelloInsiderSell896$10.38$9,300.48 11/21/2024Gaurav ShahCEOSell11,091$13.05$144,737.55 11/21/2024John MilitelloInsiderSell1,224$13.05$15,973.20 11/21/2024Martin WilsonGeneral CounselSell1,175$13.05$15,333.75 7/22/2024John MilitelloInsiderSell812$23.02$18,692.24 7/8/2024Mark Andrew WhiteInsiderSell3,026$20.39$61,700.14 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/16/2024Gaurav ShahCEOSell9,790$23.35$228,596.50 5/16/2024John MilitelloInsiderSell1,079$23.35$25,194.65 5/16/2024Martin WilsonGeneral CounselSell1,048$23.35$24,470.80 (Data available from 1/1/2013 forward) RCKT Insider Trading Activity - Frequently Asked Questions Who is on Rocket Pharmaceuticals's Insider Roster? The list of insiders at Rocket Pharmaceuticals includes Aaron Ondrey, David P Southwell, Gaurav Shah, Gotham Makker, John Militello, Jonathan David Schwartz, Kinnari Patel, Mark Andrew White, Martin Wilson, and Rtw Investments, Lp. Learn more on insiders at RCKT. What percentage of Rocket Pharmaceuticals stock is owned by insiders? 28.50% of Rocket Pharmaceuticals stock is owned by insiders. Learn more on RCKT's insider holdings. Which Rocket Pharmaceuticals insiders have been buying company stock? The following insiders have purchased RCKT shares in the last 24 months: Gaurav Shah ($101,600.00), and Kinnari Patel ($99,165.30). How much insider buying is happening at Rocket Pharmaceuticals? Insiders have purchased a total of 41,099 RCKT shares in the last 24 months for a total of $200,765.30 bought. Which Rocket Pharmaceuticals insiders have been selling company stock? The following insiders have sold RCKT shares in the last 24 months: Aaron Ondrey ($39,616.81), David P Southwell ($1,945,700.00), Gaurav Shah ($1,051,996.02), Gotham Makker ($8,457,281.36), John Militello ($499,600.79), Kinnari Patel ($236,549.86), Mark Andrew White ($370,488.62), and Martin Wilson ($266,765.39). How much insider selling is happening at Rocket Pharmaceuticals? Insiders have sold a total of 491,671 Rocket Pharmaceuticals shares in the last 24 months for a total of $12,867,998.85 sold. Rocket Pharmaceuticals Key ExecutivesMs. Kinnari Patel M.B.A. (Age 44)Pharm.D., Head of R&D, President & COO Compensation: $849.93k1 recent tradesMr. Mayo Pujols (Age 54)Chief Technical Officer Compensation: $649.71kMr. Raj Prabhakar M.B.A. (Age 49)Chief Business Officer Compensation: $619.13kMr. Aaron Ondrey (Age 47)Chief Financial Officer 1 recent tradesMr. Martin Louis Wilson J.D. (Age 48)General Counsel, Chief Compliance Officer & Chief Corporate Officer Compensation: $149.95kKevin GiordanoDirector of Corporate CommunicationsMs. Isabel Carmona J.D.Chief People OfficerMr. Jonathan Schwartz M.D. (Age 59)Chief Medical & Gene Therapy Officer Compensation: $557.79kDr. Gayatri R. Rao J.D.M.D., Senior VP of Clinical Safety & Chief Regulatory OfficerMr. Carlos MartinChief Commercial Operations & Revenue Officer More Insider Trading Tools from MarketBeat Related Companies Scholar Rock Insider Ownership Viking Therapeutics Insider Ownership Xenon Pharmaceuticals Insider Ownership Catalyst Pharmaceuticals Insider Ownership Protagonist Therapeutics Insider Ownership Immunovant Insider Ownership MoonLake Immunotherapeutics Insider Ownership ACADIA Pharmaceuticals Insider Ownership Twist Bioscience Insider Ownership Amneal Pharmaceuticals Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:RCKT) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RCKT Stock Free RCKT Stock Alerts